Clin2
NCT07490769Possibly a fitRecruiting

Taking levetiracetam three times daily for epilepsy

Epilepsy

Treatments studied

Part of Brain & nervous system clinical trials.

This trial is for adults with uncontrolled epilepsy who have been taking a high dose of Levetiracetam alone for at least a year. It tests whether taking Levetiracetam three times a day works better than the usual schedule.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
120 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have epilepsy that is not fully controlled (at least one seizure in the last 6 months).
  • You are taking only Levetiracetam (no other seizure medicines).
  • You have been on Levetiracetam for at least 12 months.
  • Your current daily dose of Levetiracetam is between 1.5 and 3 grams.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05450822Recruiting
Personalized testing to guide treatment for epilepsy

This trial uses detailed brain tests to better match people with epilepsy to the right treatment. It may help by using “precision medicine” methods to understand what in the brain is driving seizures.

Copenhagen
NCT07234695Recruiting· Phase 3
Levetiracetam to prevent seizures in adults with Down syndrome and Alzheimer's

This trial tests if levetiracetam, a seizure medication, can prevent seizures in adults with Down syndrome who also have Alzheimer's disease. It aims to help manage a common complication and improve quality of life.

Granada, Andalusia
NCT04715646Recruiting· Phase 3
Brivaracetam study for children with hard-to-control seizures

This trial looks at how safe brivaracetam is and how well it can be used in children and teens with certain types of epilepsy that are not well controlled. It may help families who are dealing with frequent focal seizures despite taking seizure medicines.

Hawthorne, New York
NCT05610085Recruiting· Phase 2
Levetiracetam for newborn seizures: dose-finding study

This trial studies how to give levetiracetam to newborn babies with seizures. It’s trying to find a safe dose and see if it can help control seizures in early life.

San Diego, California
NCT07098728Recruiting
Levetiracetam vs Phenobarbital for prolonged seizures in children

This trial compares two antiseizure medicines, levetiracetam and phenobarbital, to see which one works better for children whose prolonged seizures (lasting several minutes) do not stop after two doses of a rescue medicine called benzodiazepine.

Yangon, Yangon
NCT06442748Recruiting· Phase 3
Short vs long seizure medicine in brain tumor patients

This study compares stopping seizure medicine (levetiracetam) after 6 months versus continuing it longer for people with primary brain tumors. It aims to find out if it is safe to stop the medication sooner and may help you avoid long-term side effects.

Udupi, Karnataka

Hear when a new Epilepsy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.